Neurologist and clinical researcher, Department of Neurology, Helsinki University Hospital
Founder and CEO, NeuroInnovation Oy
Filip Scheperjans, M.D., Ph.D., studied medicine at the University of Düsseldorf (Germany) and gained international experience as a visiting student in London, New York and Helsinki. His doctoral thesis under Prof. Karl Zilles (C & O Vogt Institute for Brain Research, University of Düsseldorf and Institute of Medicine, Research Center Jülich, Germany) was concerned with the cytoarchitectonical and neurochemical anatomy of the human parietal lobe. He received the award for the best thesis of the medical faculty of the University of Düsseldorf in 2008. Now living in Finland he works as neurologist and clinical researcher at the Department of Neurology of Helsinki University Hospital. His main research interest is the role of microbiota in Parkinson’s disease and his group was the first to demonstrate microbiome community structure alterations in Parkinson’s disease. For his groundbreaking work in this field he was awarded the Uschi Tschabitscher Prize for Young Neurologists by the European Academy of Neurology in 2014. His work on gut microbiota in PD is continuing in longitudinal studies. Since 2015 Filip Scheperjans is also founder and CEO of NeuroInnovation Oy, a company providing state-of-the art clinical services to Parkinson patients and working on developing microbiome based treatments for PD. He is furthermore involved in several international multicenter trials related to Parkinson’s disease.